Dividends Calendar Earnings Calendar
OVID

OVID | Ovid Therapeutics Inc

Healthcare sector
Ovid Therapeutics Inc
Category: Consumer goods
  • Industry: Biotechnology

Quick infos

  • Headquarters:   United States of America

Trade prices

  • Volume:
  • Market Cap: 204.91M
  • Prev closed: 4.02
  • Open: 4.03
  • High: 4.14
  • Low: 3.97
  • 52 week low: 2.25
  • 52 week high: 9.4
  • Dividends:No Dividends

Next ER: August 11, 2022 



Top Stories (OVID)

    Company Profile

    Ovid Therapeutics Inc. is a New York-based biopharmaceutical company using its BoldMedicine® approach to develop medicines that transform the lives of patients with rare neurological disorders. Ovid has a broad pipeline of potential first-in-class medicines. The company?s most advanced investigational medicine, OV101 (gaboxadol), is currently in clinical development for the treatment of Angelman syndrome and Fragile X syndrome. Ovid is also developing soticlestat in collaboration with Takeda Pharmaceutical Company Limited for the potential treatment of rare developmental and epileptic encephalopathies (DEE).

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    November 10, 2022
    August 11, 2022- / -0.233- / -
    May 10, 2022-0.23 / -0.20721.45M / -Beat!
    March 15, 2022-0.38 / -0.1611- / -
    November 11, 2021- / -0.1657- / -
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Aug 15, 2022 2.270 2.210
    2.277
    2.210
    		 37.19K 0.89%
    Aug 12, 2022 2.250 2.200
    2.265
    2.200
    		 77.64K 1.35%
    Aug 11, 2022 2.220 2.200
    2.230
    2.190
    		 98.76K 0.45%
    Aug 10, 2022 2.210 2.200
    2.230
    2.190
    		 31.61K 1.38%
    Aug 9, 2022 2.180 2.170
    2.220
    2.141
    		 37.02K -0.91%
    Aug 8, 2022 2.200 2.180
    2.220
    2.170
    		 30.68K 0%
    Aug 5, 2022 2.200 2.170
    2.210
    2.170
    		 35.71K 0%
    Aug 4, 2022 2.200 2.200
    2.220
    2.160
    		 26.62K -0.9%
    Aug 3, 2022 2.220 2.200
    2.285
    2.155
    		 328.75K 0.91%
    Aug 2, 2022 2.200 2.093
    2.200
    2.050
    		 221.50K 5.77%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:2014
    • Employees:67

    News

    News for (OVID)

    This company doesn't provide a dividend.


    Talk about Ovid Therapeutics Inc below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Aug 11, 2022 (Same day)

    viav viab ilmn cah hbi flo usfd pags suz ortx azul atge 


    Jump to (Finance sites)

    Google   
             

    Research 


    Investor page

    investors.ovidrx.com

    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 50
    HOLD 50
    SELL 0

    Their Official Profiles 

    TwitterLinkedInInstagramYoutube

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    Investing For Dummies
    Buy on Amazon

    In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.